[go: up one dir, main page]

WO2008003044A3 - Method and apparatus for human behavioral monitoring - Google Patents

Method and apparatus for human behavioral monitoring Download PDF

Info

Publication number
WO2008003044A3
WO2008003044A3 PCT/US2007/072359 US2007072359W WO2008003044A3 WO 2008003044 A3 WO2008003044 A3 WO 2008003044A3 US 2007072359 W US2007072359 W US 2007072359W WO 2008003044 A3 WO2008003044 A3 WO 2008003044A3
Authority
WO
WIPO (PCT)
Prior art keywords
hbpm
human
present
provides
paradigm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/072359
Other languages
French (fr)
Other versions
WO2008003044A2 (en
Inventor
William Perry
Mark Geyer
Arpi Minassian
Martin Paulus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of WO2008003044A2 publication Critical patent/WO2008003044A2/en
Publication of WO2008003044A3 publication Critical patent/WO2008003044A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
    • A61B5/1104Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb induced by stimuli or drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
    • A61B5/1113Local tracking of patients, e.g. in a hospital or private home
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/16Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165Evaluating the state of mind, e.g. depression, anxiety
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/16Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/168Evaluating attention deficit, hyperactivity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00Evaluating a particular growth phase or type of persons or animals
    • A61B2503/06Children, e.g. for attention deficit diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00Evaluating a particular growth phase or type of persons or animals
    • A61B2503/40Animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00Evaluating a particular growth phase or type of persons or animals
    • A61B2503/42Evaluating a particular growth phase or type of persons or animals for laboratory research

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dentistry (AREA)
  • Educational Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides a human paradigm, namely, human behavioral pattern monitor (hBPM), that is analogous to an animal paradigm, and a method of use thereof, for validating rodent animal models of psychiatric diseases. The present invention further provides a translational approach to utilize measures characterizing rodent locomotor behavior for application in human locomotor behavior using hBPM in neuropsychiatry disorders, such as bipolar disorder. Furthermore, the present invention provides that the hBPM can be used to characterize hyperactivity, differentiate diagnostic groups, or study habituation, and further provides a potential measure of drug efficacy, and assessment of the effects of medications on cognition.
PCT/US2007/072359 2006-06-28 2007-06-28 Method and apparatus for human behavioral monitoring Ceased WO2008003044A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80606006P 2006-06-28 2006-06-28
US60/806,060 2006-06-28

Publications (2)

Publication Number Publication Date
WO2008003044A2 WO2008003044A2 (en) 2008-01-03
WO2008003044A3 true WO2008003044A3 (en) 2008-07-10

Family

ID=38846548

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/072359 Ceased WO2008003044A2 (en) 2006-06-28 2007-06-28 Method and apparatus for human behavioral monitoring

Country Status (1)

Country Link
WO (1) WO2008003044A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200831446A (en) 2006-11-15 2008-08-01 Du Pont Processes for producing pentafluoropropenes and certain azeotropes comprising HF and certain halopropenes of the formula C3HCIF4
CN106999049B (en) * 2014-11-25 2021-03-23 皇家飞利浦有限公司 System and method for modulating duration of sensory stimulation during sleep to enhance slow wave activity
US9978145B2 (en) * 2014-12-16 2018-05-22 Koninklijke Philips N.V. Assessment of an attentional deficit
EP3468545A4 (en) 2016-06-08 2020-07-22 President and Fellows of Harvard College METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY RELATED TO AUTISM SPECTRUM DISORDER, RETT SYNDROME AND FRAGILE X SYNDROME
AU2019272778B2 (en) 2018-05-22 2024-10-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
EP3801512A4 (en) 2018-05-29 2022-01-19 President and Fellows of Harvard College COMPOSITIONS AND METHODS TO REDUCE TACTILE DYSFUNCTION, ANXIETY AND SOCIAL DISABILITIES
US12077512B2 (en) 2019-03-25 2024-09-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
EP3972595A4 (en) * 2019-05-22 2023-08-02 President and Fellows of Harvard College TEST FOR INHIBITION OF TACTILE PREPULSE IN HUMANS
EP3766423A1 (en) * 2019-07-19 2021-01-20 Vasilios Chatzatoglou Device and method for detecting a possible abnormal human behaviour
CN111374681B (en) * 2020-04-24 2024-11-12 南京医科大学 A detection device and a detection method for animal anhedonia behavior

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100998A2 (en) * 2001-05-15 2003-05-29 Carnegie Mellon University (Pittsburgh, Pa) And Psychogenics, Inc. (Hawthorne, Ny) Systems and methods for monitoring behavior informatics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100998A2 (en) * 2001-05-15 2003-05-29 Carnegie Mellon University (Pittsburgh, Pa) And Psychogenics, Inc. (Hawthorne, Ny) Systems and methods for monitoring behavior informatics

Also Published As

Publication number Publication date
WO2008003044A2 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
WO2008003044A3 (en) Method and apparatus for human behavioral monitoring
Ahnaou et al. Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity
WO2010082944A3 (en) Systems and methods for imaging changes in tissue
ATE516748T1 (en) DEVICE FOR TREATING MOTION DISORDERS
ATE524149T1 (en) DEVICE AND SYSTEM FOR COMPRESSION TREATMENT OF A BODY PART
Çelik et al. Therapeutic effects of thymoquinone in a model of neuropathic pain
BRPI0519739A2 (en) combination comprising an agent providing a signal, an implant material and a drug
ATE490726T1 (en) BIOFEEDBACK SYSTEM AND DISPLAY DEVICE
ATE502570T1 (en) METHOD AND DEVICE FOR FAST PRESSURE EEG ELECTRODE
Sycha et al. Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model
BR112017014694A8 (en) SYSTEM, DEVICE, MONITOR, SENSOR RANGE AND METHOD FOR THE MEASUREMENT OF AUTONOMIC FUNCTION FOR DIAGNOSIS AND VALIDATION OF TREATMENTS AND PATIENT RESULTS
DE602004007115D1 (en) DEVICE FOR MAINTAINING CONTACT BETWEEN ELECTROPHYSIOLOGY ELEMENTS AND BODY TISSUE AND SYSTEM THEREFOR
EP2376759A4 (en) DIAGNOSTIC METHOD AND APPARATUS FOR AN EXHAUST PRESSURE REGULATOR
WO2007114901A3 (en) Method for diagnosing adhd and related behavioral disorders
BRPI0915893A2 (en) methods and apparatus for introducing a medical device into a patient's body
EP1938750A3 (en) Method of therapeutic drug monitoring
Capra et al. Human and animal experimental models of acute and chronic muscle pain: intramuscular algesic injection
WO2007098142A3 (en) Oxazole ketones as modulators of fatty acid amide hydrolase
O'Neill et al. Human psychophysics and rodent spinal neurones exhibit peripheral and central mechanisms of inflammatory pain in the UVB and UVB heat rekindling models
Tonelli et al. Awakenings in rats by ultrasounds: A new animal model for paradoxical kinesia
Nissen et al. Translational aspects of rectal evoked potentials: a comparative study in rats and humans
Driessen Pain: from sign to disease
Samineni et al. Post-ictal analgesia in genetically epilepsy-prone rats is induced by audiogenic seizures and involves cannabinoid receptors in the periaqueductal gray
DE602007012684D1 (en) DEVICE FOR MEDICINAL ADMINISTRATION AND / OR MONITORING OF A PATIENT'S CONDITION
Kaka et al. Validation of a modified algometer to measure mechanical nociceptive thresholds in awake dogs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812423

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07812423

Country of ref document: EP

Kind code of ref document: A2